OBaris AG (former Transire Bio) won Stage 3 Venture Kick
Congratulations to the team for another win!
Our lab's spin-off, external page OBaris, is one step closer to start validating their regulatory strategy. Nevena and David are now preparing for a fundraise with international investors, and will swap roles from April 2024.
Read the entire news here: external page CHF 150'000 for painless drug delivery.